Kitayama Mitchell W 4

What Happened

• Mitchell W. Kitayama, a director of Astrana Health, Inc. (ASTH), received a grant of 4,991 restricted shares on June 10, 2026. The Form 4 reports an acquisition price of $0.00 for the award (i.e., a compensatory grant rather than a market purchase).

Key Details

• Transaction date: June 10, 2026; filing date: June 12, 2026 (filed within the typical 2-business‑day Form 4 window).
• Transaction type/code: Award/Grant (A).
• Shares acquired: 4,991 restricted shares; reported acquisition amount: $0.00.
• Vesting: Per footnotes, shares vest on the earlier of (i) June 10, 2027 or (ii) the date of Astrana Health’s 2027 annual meeting; grant made under the Issuer’s 2024 Equity Incentive Plan.
• Shares owned after transaction: Not specified in the information provided.
• No 10b5-1 plan, tax‑withholding sale, or cashless exercise noted in the filing excerpts provided.

Context

• This is a typical director compensation award (restricted stock) rather than an open‑market purchase or sale. Restricted shares are subject to vesting and are not immediately liquid, so the grant signals compensation/retention rather than an immediate insider market view.